NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/04/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,033.62 mln
Float25.44 mln
Earnings Date11/10/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
54.64
Strong upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-935
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Faeth Therapeutics, formerly Sensei Biotherapeutics, is a clinical-stage biotech company based in Rockville, Maryland, focused on developing new treatments for cancer. Its lead programs include PIKTOR, which targets a key cell growth pathway in endometrial and breast cancer, and Solnerstotug, an antibody designed to help the immune system fight solid tumors. The company also has several earlier-stage drugs in development aimed at treating various solid tumor types.
